Georgia's Online Cancer Information Center


back

Uterine Cancer Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Uterine Cancer
Cancer Type = Uterine Cancer
NCI ID Cancer Type Trial Name
There are currently 15 active Uterine Cancer clinical trials in Georgia.
NCI ID Cancer Type Trial Name
1.
NCORP Trial
A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma
Cancer Type
Ovarian Cancer, Solid Tumor, Unknown Primary, Uterine Cancer
NCT ID
NCT05548296
Protocol IDs
ACR-368-201 (GOG 3082)
NCI-2022-10629
Treatment Sites (2)
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
Winship Cancer Institute of Emory University
Atlanta
2.
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Cancer Type
Solid Tumor, Unknown Primary, Uterine Cancer
NCT ID
NCT05787587
Protocol IDs
IDE161-001
NCI-2023-03139
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
3.
NCORP Trial
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma
Cancer Type
Unknown Primary, Uterine Cancer
NCT ID
NCT04814108
Protocol IDs
ZN-c3-004
NCI-2021-11201
Treatment Sites (1)
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
4.
NCORP Trial
EHR Tool in Assessing Heart Health among Cancer Survivors
Cancer Type
Breast Cancer, Colon/Rectal Cancer, Hematopoietic Malignancies, Hodgkin Lymphoma, Lymphoma, Non-Hodgkin Lymphoma, Prostate Cancer , Solid Tumor, Unknown Primary, Uterine Cancer
NCT ID
NCT03935282
Protocol IDs
WF-1804CD
WF-1804CD
WF-1804CD
NCI-2019-01362
Treatment Sites (1)
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
5.
Evaluation of Sexual Toxicities in Women After Pelvic Radiotherapy
Cancer Type
Anal Cancer, Cervical Cancer, Colon/Rectal Cancer, Gynecologic Cancers, Solid Tumor, Uterine Cancer
NCT ID
NCT05394428
Protocol IDs
20-2369
NCI-2022-05850
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
6.
NCORP Trial
Selinexor in Maintenance Therapy After Systemic Therapy for Participants with P53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma
Cancer Type
Unknown Primary, Uterine Cancer
NCT ID
NCT05611931
Protocol IDs
XPORT-EC-042
NCI-2023-01755
ENGOT-EN20
GOG-3083
Treatment Sites (1)
Northeast Georgia Medical Center - Gainesville
Gainesville
Trena Davis
770-219-8822
7.
NCORP Trial
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Cancer Type
Unknown Primary, Uterine Cancer
NCT ID
NCT05797831
Protocol IDs
KRT-232-118
NCI-2024-03038
ENGOT en-21
GOG-3089
8.
Study of PYX-106 in Solid Tumors
Cancer Type
Uterine Cancer
NCT ID
NCT05718557
Protocol IDs
PYX-106-101
NCI-2023-03477
2022-002306-24
2023-509686-21-00
Treatment Sites (1)
Winship Cancer Institute of Emory University
Atlanta
9.
NCORP Trial
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
Cancer Type
Unknown Primary, Uterine Cancer
NCT ID
NCT06486441
Protocol IDs
GS-US-682-6769
NCI-2024-05881
2024-511957-23
APGOT-EN2
ENGOT-en26
GOG-3104
Treatment Sites (1)
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
10.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Cancer Type
Brain Tumor, Colon/Rectal Cancer, Liver Cancer / Hepatoblastoma, Melanoma, Neuroblastoma, Non-Hodgkin Lymphoma, Ovarian Cancer, Sarcoma, Uterine Cancer, Wilms Tumor
NCT ID
NCT04851119
Protocol IDs
PEPN2011
PEPN2011
NCI-2021-02852
11.
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Cancer Type
Ovarian Cancer, Uterine Cancer
NCT ID
NCT05950464
Protocol IDs
NRG-GY031
NRG-GY031
NCI-2023-03408
Treatment Sites (1)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
12.
Testing Nivolumab with or without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Cancer Type
Unknown Primary, Uterine Cancer
NCT ID
NCT05112601
Protocol IDs
NRG-GY025
NRG-GY025
NCI-2021-11881
Treatment Sites (1)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
13.
NCORP Trial
Testing Olaparib and Temozolomide versus the Usual Treatment for Uterine Leiomyosarcoma after Chemotherapy Has Stopped Working
Cancer Type
Sarcoma, Unknown Primary, Uterine Cancer
NCT ID
NCT05432791
Protocol IDs
A092104
A092104
NCI-2022-05065
NCT05432791
14.
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment with the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
Cancer Type
Unknown Primary, Uterine Cancer
NCT ID
NCT05538897
Protocol IDs
NRG-GY028
NRG-GY028
NCI-2022-07505
Treatment Sites (1)
Augusta University Medical Center
Augusta
Carol Terry
706-721-4430
15.
NCORP Trial
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Cancer Type
Uterine Cancer
NCT ID
NCT05256225
Protocol IDs
NRG-GY026
NRG-GY026
NCI-2022-01540
Treatment Sites (4)
Bluffton Campus at St. Joseph's/Candler
Bluffton
Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler
Savannah
Alaina Underberg
912-819-5778
St. Joseph's /Candler Health System, INC
Savannah
Stephanie J. Reyes
912-819-5723
St. Joseph's /Candler Health System, INC
Savannah
About Us Research Resources & Education Screening & Genetics Clinical Trials & Providers Cancer Navigators Survivorship Media, News & Events Contact Us Donate Take Our Survey Link to Us

Research

Screening & Genetics

Find Cancer Care

Survivorship

About Georgia CORE

Education & Resources

Media, News & Events

Patient Navigation

Georgia CORE

 

Georgia CORE bridges the gap between groundbreaking research, educational outreach, and effective advocacy to transform the landscape of cancer care for all Georgians.